openPR Logo
Press release

Heparin Market to Attain a Value of US$16.3 bn by 2025

10-10-2019 03:46 PM CET | Health & Medicine

Press release from: Transparency Market Research

Global Heparin Market: Snapshot

The global heparin market is anticipated to attract growth opportunities on the back of the rising count of surgical procedures and increasing treatment of venous thromboembolism (VTE) including pulmonary embolism (PE) and deep vein thrombosis (DVT). Anticoagulant heparin holds the ability to reduce blood clotting. It could be used in blood transfusion, blood samplings during prophylaxis treatment, and the treatment of blood clotting disorders.

As per the analysis of the report, the global heparin market could expand at a CAGR of 6.2% for the forecast period 2017–2025 to reach a valuation of US$16.3 bn by the end of 2025. In 2017, the market attained a valuation of US$10.1 bn.

Obtain Report Details @ https://www.transparencymarketresearch.com/heparin-market.html

LMWH Wins by Share, ULMWH Impresses by Novelty

As studied by the analysts, the world heparin market could be segmented on the basis of product, source, and formulation. By product, the market is predicted to encompass three segments, viz. unfractionated heparin (UFH), low molecular weight heparin (LMWH) and ultra-low molecular weight heparin (ULMWH). Amongst these products, LMWH had accounted for a king’s share in the recent past and is a widely used heparin to this date.

Generic and biosimilar drug manufacturers are expected to be empowered with growth opportunities birthing from the patent expiration of a majority of LMWHs. Since LMWH does not cross the placenta, it has been recommended as one of the most appropriate forms of heparin to be used during pregnancy by the Royal College of Obstetrics and Gynecology (RCOG) and National Institute for Health and Care Excellence (NICE). However, ULMWH is still used as a more novel therapeutic among the products in the heparin family.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=803

As per a segmentation by source, the world heparin market is prognosticated to be classified into bovine and porcine. After its ban in the U.S. and Europe in the 90’s, bovine-sourced heparin had been proposed by the Center for Drug Evaluation and Research (CDER) to be reintroduced in the U.S. By formulation, the market could be divided into oral and parenteral.

Long-term DVT/PE Complications Catapult North America

In terms of regional segmentation, the international heparin market is envisaged to witness the dominance of North America followed by Europe in the coming years. By the completion of the forecast timeframe, North America could be leading the market with a US$6.0 bn secured under its belt. An estimate one-third of the DVT/PE patients in the U.S. could have a recurrence within 10 years and nearly half of them could develop long-term complications. Increasing incidences of coagulation disorders and burgeoning geriatric population are prophesied to help the Europe market to achieve a handsome growth in the near future.

Not to forget, Asia Pacific could be a faster growing region of the international heparin market rising at a 7.6% CAGR due to its largely untapped nature. The probability of PE in India, according to the National Institute of Health Consensus, is close to a 20.0%, whereas the overall incidence of DVT after elective hip surgery is approximately a 45.0% to 70.0%. The Middle East and Africa and Latin America are foreseen to tread upon the heels of Asia Pacific.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=803

Some of the prominent companies operating in the worldwide heparin market could include Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Sanofi, Pfizer, Inc., LEO Pharma A/S, Aspen, Baxter International Inc., B. Braun Melsungen AG, and Syntex S.A.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heparin Market to Attain a Value of US$16.3 bn by 2025 here

News-ID: 1846364 • Views: 175

More Releases from Transparency Market Research

Diabetic Macular Edema Market In-depth Analysis, Business Strategies, and Growth …
Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling. Due to such swelling, a person’s central eye vision gets distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME). Read Report Overview - https://www.transparencymarketresearch.com/diabetic-macular-edema-market.html Diabetic macular edema is the major reason for loss of vision in patients suffering
Wireless Patient Monitoring Market is Booming Worldwide Scrutinized in New Resea …
Wireless patient monitoring devices are wireless and remote technologies that monitor and transmit data either within an institution or hospital via wireless or intranet, or at a remote location, using wireless transmissions. It would be a very difficult task to keep track of the patient data and information in a multi-specialty hospital with large set ups, wherein there is a regular flow of critical care patients and out-patients. Read Report Overview
Personal Dosimeter Market Status and Forecast, by Players, Types and Application …
Personal dosimeter is a sophisticated device that monitors the dose of ionizing radiation and warns with an alarm, once the acceptable dose rate limit is exceeded. The alarm released could be audible or visual or both, depending on the device. Read Report Overview - https://www.transparencymarketresearch.com/personal-dosimeter-market.html A personal dosimeter tracks the changes in exposure and keeps an ongoing record of dose gained by the user over time. It is possible to limit total
Potential Impact of COVID-19 on Intelligent Virtual Assistant Market
Speech Recognition Software Preferred in Hospitals to Reduce Overheads amidst COVID-19 The South Asian Association for Regional Cooperation (SAARC) is deploying speech recognition support to clients who are keen on purchasing speech recognition software for commercial purposes. Speech recognition software are in high demand amidst the COVID-19 (coronavirus) pandemic in order to provide remote services to users in the realms of banking and financial services and the retail shopping sector. Thus, companies

All 5 Releases


More Releases for LMWH

Injectable Anticoagulants Market: Huge Growth Opportunities and Challenges to Wa …
Injectable Anticoagulants Market report includes (5 Year Forecast 2019-2024) an extensive analysis of competition by topmost prime manufacturers (Sanofi, Genentech (Roche), Boehringer Ingelheim, Pfizer, The Medicines Company , Aspen, Otsuka) which providing various attributes such as Company Profiles, Product Picture and Specification, Business Strategies, Recent Developments, Capacity, Production, Price, Cost, Revenue and contact information. The Injectable Anticoagulants market report provides a basic summary of the business together with definitions, classifications, applications and business chain structure. The
Global Heparin Market: Segment Snapshot and Table of Content (2017-2027)
TMR has envisaged the global heparin market to earn an around US$16.3 bn by the end of 2025 while rising at a CAGR of 6.2% during the forecast time frame 2017-2025. In 2017, the market earned an approximately US$10.1 bn. With respect to segmentation by product, low molecular weight heparin (LMWH) could account for a colossal share in the market by the completion of the forecast period. Regionally, North America
Heparin Market is Expected to Reach at Value US$ 16,385.7 Mn and Volume 36.7 Mil …
According to the report, the global heparin market was valued at US$ 9,549.0 Mn in 2016 and is projected to expand at a CAGR of 6.2% during forecast period from 2017 to 2025 to reach US$ 16,385.7 Mn in 2025. The global heparin market volume was accounted for 28.8 million megas in 2016 and is expected to grow at a CAGR of 2.7% during the forecast period from 2017 to
United States Injectable Anticoagulants Market by Manufacturers, States, Type an …
ReportsWorldwide has announced the addition of a new report title United States Injectable Anticoagulants Market by Manufacturers, States, Type and Application, Forecast to 2022 to its growing collection of premium market research reports. The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin], enoxaparin [Lovenox]) and factor Xa inhibitors (fondaparinux [Arixtra]). In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism. Scope of
Global Anticoagulants Market Size, Shares, Segments, Trends & Forecasts (2016-20 …
The report entitled Global Anticoagulants Market: Size, Trends & Forecasts (2016-2020) provides an analysis of the global anticoagulants market with detailed description of market size & growth and market share by products. The report also provides a detailed analysis of anticoagulants available in the market. Details of Lovenox, Arixtra, Fraxiparine (injectable anticoagulants), Xarelto, Pradaxa and Eliquis (NOACs) has provided in terms of their worldwide sales. The report provides detailed regional analysis of
New study on Global Anticoagulants Market Size, Growing Rapidly, Trends & Foreca …
The report entitled Global Anticoagulants Market: Size, Trends & Forecasts (2016-2020) provides an analysis of the global anticoagulants market with detailed description of market size & growth and market share by products. The report also provides a detailed analysis of anticoagulants available in the market. Details of Lovenox, Arixtra, Fraxiparine (injectable anticoagulants), Xarelto, Pradaxa and Eliquis (NOACs) has provided in terms of their worldwide sales. The report provides detailed regional analysis of